Gordon Hartogensis, a director at Lands’ End, Inc. (NASDAQ: LE), disclosed a sale of 752 shares of the company’s common stock on April 1, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The shares were sold at $45.00 apiece for an aggregate proceeds amounting to $33,840. After completing the transaction, Hartogensis retained direct ownership of 9,142 shares.
Market movement since the sale has been material. Lands’ End shares are currently trading at $10.90, representing roughly a 21% year-to-date decline from prior levels. Independently, InvestingPro’s analysis places the stock below its calculated intrinsic level, assigning a Fair Value of $14.90. The company carries a market capitalization of $337 million and is trading at a price-to-earnings ratio of 60.91.
Recent company results provide context for investor reactions. In its fourth quarter for fiscal year 2025, Lands’ End reported earnings per share of $0.76, which fell short of an expected $0.79. Revenue for the quarter came in at $462.4 million, missing the anticipated $472.24 million, although the company did record a 5% increase in total revenue compared with the same period in the prior year.
Alongside the quarterly report, Lands’ End announced that its Board of Directors has authorized a share repurchase program of up to $100 million of common stock to be available through March 31, 2029. The company said it intends to carry out repurchases via open market transactions, privately negotiated transactions, or by other means permitted under federal securities laws.
Summary of the transaction and company metrics:
- Insider sale: 752 shares sold on April 1, 2026, at $45.00 per share, for total proceeds of $33,840.
- Post-transaction insider holding: 9,142 shares directly owned by Hartogensis.
- Current trading price: $10.90; year-to-date loss of approximately 21%.
- Valuation snapshot: InvestingPro Fair Value $14.90; market cap $337 million; P/E 60.91.
- Latest quarter: EPS $0.76 vs. forecast $0.79; revenue $462.4 million vs. expected $472.24 million; total revenue increased 5% year-over-year.
- Buyback authorization: Up to $100 million through March 31, 2029, to be executed in accordance with federal securities laws.
This disclosure reflects the filing details and the company-reported financial results. The reported insider sale, current market price, valuation estimate, quarterly results and share repurchase authorization are presented as reported; no additional interpretation beyond these reported data points is provided here.